People · Operator
Named in public records as an officer, director or promoter · active 2009–2022 · Biotechnology, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CircuLite Inc | — | Biotechnology | Series A | $22.0M | $415.7M | 2009 |
| Cardiac Implants LLC | — | Biotechnology | Series A | $13.5M | $178.4M | 2022 |
| Cyrano Therapeutics, Inc. | — | Pharma | Series A | $4.1M | $108.4M | 2020 |
Richard Geoffrion at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard Geoffrion on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Barry | 1 | 5 |
| Gerry Brunk | 1 | 5 |
| JEFFREY BARNES | 1 | 3 |
| Takahide Koda | 1 | 3 |
| Peter Pfreundschuh | 1 | 2 |
| Paul Southworth | 1 | 2 |
| Lee Wrubel, M.D. | 1 | 2 |
| Tricia Wright | 1 | 1 |
| Alexia Perouse | 1 | 1 |
| Stephen Magowan | 1 | 1 |
| Michael Butscheidt | 1 | 1 |
| Mark Turco | 1 | 1 |
| Robert Henkin | 1 | 1 |
| Avi Molcho | 1 | 1 |
| Martien Van Osch | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.